Morniflumate

This classification denotes an anti-infective agent with the molecular formula C19H20F3N3O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier R133MWH7X1, chemically known as 3-pyridinecarboxylic acid, 2-((3-(trifluoromethyl)phenyl)amino)-, 2-(4-morpholinylethyl) ester but generally known as morniflumate, which bears US NIH Compound Identifier 72106. European Medicines Agency schedules Morniflumate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09068MIG. The term MORNIFLUMATE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 33, No. 10 1979, List 19). World Health Organization schedules morniflumate in its Anatomical Therapeutic Chemical (ATC) Classification. MORNIFLUMATE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule morniflumate under HS 29349990 and SITC 51579. As of Q4 2014, MORNIFLUMATE remains the US FDA Preferred Term for this commodity. Morniflumate bears US NLM identifiers UMLS ID C0066803 and NCI Concept Code C66198. SMILES: FC(F)(F)C1CC(NC2NCCCC2C(=O)OCCN2CCOCC2)CCC1.